Joseph A. Sparano, Montefiore Einstein Center for Cancer Care (IMAGE)
Caption
Dr. Joseph A. Sparano is the study chair for the historic TAILORx clinical trial evaluating the use of the Oncotype DX(r) test to identify which women with early-stage breast cancer are at low risk of recurrence and thus, may forego chemotherapy and be treated with hormone therapy alone.
Credit
Montefiore Einstein Center for Cancer Care
Usage Restrictions
None
License
Licensed content